Featured Article
Executive perspectives: Mark Read
27th January 2012 | Register to comment
To launch a new aspect of our “perspectives” interviews, Paul Tunnah talks to Mark Read, CEO of WPP Digital, to hear his insights on digital from the C-level vantage point.
At pharmaphorum, we’re constantly striving to speak to different stakeholders in the healthcare space to hear their perspectives on the industry, with…
Read the full articleCareers Management26th January 2012 | Register to comment
Gail Sampson offers tips on how to manage your career within the pharma industry. Be honest, how often do you think of your career long term? With so much changing in the industry on a day-to-day basis, the likelihood is… | Spotlight on…. pituitary disorders25th January 2012 | 2 comments
Retired GP and Pituitary Foundation trustee Dr Mark Pharaoh sheds some light on pituitary disease in the first of a new series that shines a spotlight on different disease areas. Pituitary disease is an uncommon illness affecting both sexes and all ages and only rarely does it run in families… |
Are apps medical devices? Part two: Apps as medical devices – the regulatory framework24th January 2012 | Register to comment
Continuing their advice on apps as medical devices Paul Dixey and Sam Walmsley explore the classification system of devices with regards to apps. In part one of this series we discussed some of the marketing and organisational steps that pharma companies should consider when… | A Collaborative Approach to Drug Development24th January 2012 | Register to comment
As Quintiles releases its latest New Health Report, Jeffrey Spaeder looks at the role of patients, payers and physicians in the clinical development process. In order for new therapies to meet the needs of all the stakeholders, an increasing emphasis by the biopharmaceutical industry on early collaborations with… |
How pharma can help scale mHealth? The three things pharma companies need to do23rd January 2012 | Register to comment
Vaibhav Gujral provides a walk through on how pharma companies can successfully penetrate the field of mobile health. Despite the global boom in mobile phone penetration, particularly in the last five years, adoption of mHealth solutions at… | Why is social media compliance important?20th January 2012 | Register to comment
Darshan Kulkarni shares his views on the importance of remaining compliant within the FDA regulations when it comes to social media use. The recent warning and untitled letters have demonstrated that the FDA is reviewing websites and social media to find instances of… |






